Science Explorer Back to mapMap
Discussion
Company · Sarasota · United States

Bridge Pharma (United States)

In research, Bridge Pharma (United States) stands highest in Medicine (#10,903 of 14,558 worldwide) and Health Sciences (#12,648 of 16,688 worldwide), over all time.

bridgepharma.comROR OpenAlex
World rank, 2022-now
#18,056
of 22,385 · #21,143 all time
Rank in United States
#2,651
of 3,332
Research works
420
▲ 60% vs 2018-21
Citations
5.5k
13.1 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
vs its own fields
0.96×
1.00× is exactly expected
Open access
37%
world 40%
International
30%
world 18%
Bridge Pharma (United States)

What is Bridge Pharma (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #10,903 of 14,558 9.1%135
Health SciencesDomain #12,648 of 16,688 9.3%154

Each strip is that field's whole ranked pool, with the notch where Bridge Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Bridge Pharma (United States) work in?

In 2022-now, 36% of research at Bridge Pharma (United States) is in Health Sciences, 29% in Physical Sciences. Its largest fields are Medicine (33%), Engineering (14%), Biochemistry, Genetics and Molecular Biology (13%). It does 1.6× the world's share of Life Sciences.

Health Sciences: 49 fractional works · 36.1% of its workMedicine: 45 fractional works · 33.1% of its workGenetics: 5 fractional works · 4.0% of its workPulmonary and Respiratory Medicine: 5 fractional works · 3.7% of its workOncology: 3 fractional works · 2.5% of its workPhysiology: 3 fractional works · 2.4% of its workNephrology: 3 fractional works · 2.1% of its workHematology: 3 fractional works · 2.1% of its workEpidemiology: 3 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.6% of its workSurgery: 2 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 1.2% of its workNeurology: 1 fractional works · 1.1% of its workPathology and Forensic Medicine: 1 fractional works · 0.9% of its workPharmacology: 1 fractional works · 0.8% of its workPsychiatry and Mental health: 1 fractional works · 0.8% of its workInfectious Diseases: 1 fractional works · 0.7% of its workImmunology and Allergy: 1 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.2% of its workFamily Practice: 0 fractional works · 0.2% of its workRheumatology: 0 fractional works · 0.2% of its workEmergency Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 2 fractional works · 1.8% of its workGeneral Health Professions: 1 fractional works · 0.6% of its workEmergency Medical Services: 1 fractional works · 0.5% of its workMedical Laboratory Technology: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 1 fractional works · 1.0% of its workNutrition and Dietetics: 1 fractional works · 1.0% of its workDentistry: 0 fractional works · 0.2% of its workOrthodontics: 0 fractional works · 0.2% of its workPhysical Sciences: 39 fractional works · 28.9% of its workEngineering: 20 fractional works · 14.5% of its workCivil and Structural Engineering: 9 fractional works · 6.9% of its workMechanical Engineering: 2 fractional works · 1.4% of its workBuilding and Construction: 2 fractional works · 1.2% of its workBiomedical Engineering: 1 fractional works · 1.0% of its workMechanics of Materials: 1 fractional works · 0.7% of its workElectrical and Electronic Engineering: 1 fractional works · 0.7% of its workIndustrial and Manufacturing Engineering: 1 fractional works · 0.6% of its workOcean Engineering: 1 fractional works · 0.5% of its workAerospace Engineering: 1 fractional works · 0.5% of its workControl and Systems Engineering: 0 fractional works · 0.4% of its workAutomotive Engineering: 0 fractional works · 0.2% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 8 fractional works · 5.6% of its workArtificial Intelligence: 4 fractional works · 2.6% of its workInformation Systems: 2 fractional works · 1.5% of its workComputer Vision and Pattern Recognition: 1 fractional works · 0.5% of its workComputational Theory and Mathematics: 1 fractional works · 0.5% of its workComputer Networks and Communications: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 5 fractional works · 3.5% of its workOrganic Chemistry: 4 fractional works · 2.9% of its workSpectroscopy: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 4 fractional works · 2.7% of its workEnvironmental Engineering: 1 fractional works · 1.0% of its workPollution: 1 fractional works · 0.7% of its workWater Science and Technology: 1 fractional works · 0.4% of its workEcology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workMaterials Science: 2 fractional works · 1.2% of its workMaterials Chemistry: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 1 fractional works · 0.9% of its workAtmospheric Science: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.2% of its workStatistics and Probability: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workLife Sciences: 31 fractional works · 22.6% of its workBiochemistry, Genetics and Molecular Biology: 18 fractional works · 13.1% of its workMolecular Biology: 13 fractional works · 9.9% of its workGenetics: 2 fractional works · 1.8% of its workClinical Biochemistry: 1 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNeuroscience: 5 fractional works · 3.6% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.2% of its workCognitive Neuroscience: 2 fractional works · 1.1% of its workBiological Psychiatry: 1 fractional works · 0.8% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 3.1% of its workImmunology: 4 fractional works · 2.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 1.5% of its workPharmaceutical Science: 1 fractional works · 1.1% of its workPharmacology: 0 fractional works · 0.2% of its workToxicology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 2 fractional works · 1.3% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workSocial Sciences: 17 fractional works · 12.4% of its workSocial Sciences: 8 fractional works · 5.7% of its workSociology and Political Science: 2 fractional works · 1.3% of its workPolitical Science and International Relations: 1 fractional works · 1.0% of its workCultural Studies: 1 fractional works · 0.9% of its workEducation: 1 fractional works · 0.8% of its workAnthropology: 1 fractional works · 0.5% of its workSafety Research: 1 fractional works · 0.5% of its workTransportation: 0 fractional works · 0.4% of its workGender Studies: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 4 fractional works · 3.0% of its workStrategy and Management: 2 fractional works · 1.3% of its workAccounting: 2 fractional works · 1.2% of its workManagement Information Systems: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 2 fractional works · 1.7% of its workClinical Psychology: 1 fractional works · 0.6% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workSocial Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 2 fractional works · 1.3% of its workEconomics and Econometrics: 1 fractional works · 0.9% of its workFinance: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 1 fractional works · 0.5% of its workLanguage and Linguistics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.2% of its workALL ITS WORKBridge Pharma(United States)135fractional works, 2022-now
Life Sciences23%Physical Sciences29%Health Sciences36%Social Sciences12%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 25 fields, with their numbers
    1. Medicine4533.1%
    2. Health Professions21.8%
    3. Nursing11.0%
    4. Dentistry00.2%
    1. Engineering2014.5%
    2. Computer Science85.6%
    3. Chemistry53.5%
    4. Environmental Science42.7%
    5. Materials Science21.2%
    6. Earth and Planetary Sciences10.9%
    7. Mathematics00.2%
    8. Energy00.2%
    9. Chemical Engineering00.1%
    10. Physics and Astronomy00.0%
    1. Biochemistry, Genetics and Molecular Biology1813.1%
    2. Neuroscience53.6%
    3. Immunology and Microbiology43.1%
    4. Pharmacology, Toxicology and Pharmaceutics21.5%
    5. Agricultural and Biological Sciences21.3%
    1. Social Sciences85.7%
    2. Business, Management and Accounting43.0%
    3. Psychology21.7%
    4. Economics, Econometrics and Finance21.3%
    5. Arts and Humanities10.5%
    6. Decision Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.46× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 3.06× its world share, 4 worksImmunology and Micro…Neuroscience: 2.23× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.35× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.23× its world share, 0 worksChemical EngineeringChemistry: 2.25× its world share, 5 worksChemistryComputer Science: 0.72× its world share, 8 worksComputer ScienceEarth and Planetary Sciences: 0.56× its world share, 1 worksEarth and Planetary …Energy: 0.20× its world share, 0 worksEnergyEngineering: 0.96× its world share, 20 worksEngineeringEnvironmental Science: 0.54× its world share, 4 worksEnvironmental ScienceMaterials Science: 0.34× its world share, 2 worksMaterials ScienceMathematics: 0.17× its world share, 0 worksMathematicsPhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyDentistry: 0.51× its world share, 0 worksDentistryHealth Professions: 0.67× its world share, 2 worksHealth ProfessionsMedicine: 1.72× its world share, 45 worksMedicineNursing: 2.11× its world share, 1 worksNursingArts and Humanities: 0.19× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.92× its world share, 4 worksBusiness, Management…Decision Sciences: 0.23× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.62× its world share, 2 worksEconomics, Econometr…Psychology: 0.55× its world share, 2 worksPsychologySocial Sciences: 0.45× its world share, 8 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.3×. Every wedge is a field page.

All 25 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics4.35×2 works
  2. Immunology and Microbiology3.06×4 works
  3. Biochemistry, Genetics and Molecular Biology2.46×18 works
  4. Chemistry2.25×5 works
  5. Neuroscience2.23×5 works
  6. Nursing2.11×1 works
  7. Medicine1.72×45 works
  8. Engineering0.96×20 works
  9. Business, Management and Accounting0.92×4 works
  10. Computer Science0.72×8 works
  11. Health Professions0.67×2 works
  12. Economics, Econometrics and Finance0.62×2 works
  13. Earth and Planetary Sciences0.56×1 works
  14. Psychology0.55×2 works
  15. Environmental Science0.54×4 works
  16. Dentistry0.51×0 works
  17. Social Sciences0.45×8 works
  18. Materials Science0.34×2 works
  19. Agricultural and Biological Sciences0.27×2 works
  20. Chemical Engineering0.23×0 works
  21. Decision Sciences0.23×0 works
  22. Energy0.20×0 works
  23. Arts and Humanities0.19×1 works
  24. Mathematics0.17×0 works
  25. Physics and Astronomy0.01×0 works

Who are the top researchers at Bridge Pharma (United States)?

Ranked on the quality score, Fredric J. Cohen, Luana Pesco Koplowitz and Liana Hennum lead among researchers whose main affiliation is Bridge Pharma (United States).

  1. 1 Fredric J. Cohen United States · #1,553,639 worldwide 2.2k citations · 68 works
  2. 2 Luana Pesco Koplowitz United States · #2,951,788 worldwide 364 citations · 21 works
  3. 3 Liana Hennum United States · #3,430,742 worldwide 5 citations · 17 works
  4. 4 Nick Bellino United States · #3,659,996 worldwide 13 citations · 30 works
  5. 5 J. P. Aldred United States · #4,261,817 worldwide 341 citations · 18 works
  6. 6 Jing Du United States · #5,201,785 worldwide 110 citations · 27 works
  7. 7 Lee Reeder United States · #5,859,559 worldwide 9 citations · 28 works
  8. 8 Jing Du United States · #5,886,864 worldwide 35 citations · 32 works
  9. 9 Hermann AM Mucke United States · #7,687,122 worldwide 1.2k citations · 298 works
All ranked researchers at Bridge Pharma (United States)

What are the most cited papers from Bridge Pharma (United States)?

The most cited paper from Bridge Pharma (United States) is "Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine" (Ling Qin, Irina Kufareva, Lauren G. Holden et al., 2015), with 394 citations. Next come "Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review" (357) and "Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia" (301).

Most cited papers
#PaperReleasedCitations
1 Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine Ling Qin, Irina Kufareva, Lauren G. Holden et al. · Science Open access 23 Jan 2015 394
2 Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review Saga Johansson, Annika Rosengren, Kate C. Young et al. · BMC Cardiovascular Disorders ReviewOpen access 7 Feb 2017 357
3 Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia Zhaohui Gu et al. · Nature Communications Open access 8 Nov 2016 301
4 Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update Kirk E. Evoy, Sarvnaz Sadrameli, Jillian Contreras et al. · Drugs Review 19 Nov 2020 240
5 Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia Andreas Kloetgen et al. · Nature Genetics Open access 23 Mar 2020 238
All 62 most cited papers, with filters and sorting

Which keywords describe research at Bridge Pharma (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Treatment, Diagnosis, Prognosis, Drug Discovery, Chronic Kidney Disease, Cardiac Amyloidosis, Transthyretin and Neuroinflammation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Treatment6▲ 3.7×16 topics
  2. Epidemiology6◆ 1.06×37 topics
  3. Diagnosis5▲ 4.1×12 topics
  4. Inflammation5▲ 1.60×23 topics
  5. Machine Learning4◆ 0.96×18 topics
  6. Prognosis4▲ 8.5×6 topics
  7. Drug Discovery4▲ 12×6 topics
  8. Chronic Kidney Disease4▲ 10×5 topics
  9. Clinical Trials3▲ 3.5×10 topics
  10. Cardiac Amyloidosis3▲ 108×1 topic
  11. Transthyretin3▲ 108×1 topic
  12. Dynamic Interaction3▲ 35×2 topics
  13. Neuroinflammation3▲ 7.8×5 topics
  14. Thrombosis3▲ 7.6×3 topics
  15. Footbridges3▲ 53×1 topic
  16. Vibration Serviceability3▲ 53×1 topic
  17. Neurological Disorders2▲ 3.3×8 topics
  18. Parathyroid Hormone2▲ 18×2 topics
  19. Cancer Therapy2▲ 2.8×10 topics
  20. JAK2 Mutation2▲ 69×1 topic
  21. Medicinal Chemistry2▲ 6.2×5 topics
  22. Myelofibrosis2▲ 69×1 topic
  23. FGF232▲ 44×1 topic
  24. phosphate2▲ 44×1 topic
  25. Hereditary Angioedema2▲ 79×1 topic
  26. Kinin Receptor Family2▲ 79×1 topic
  27. Language2▲ 5.0×2 topics
  28. Neuropathic Pain2▲ 18×2 topics
  29. Pharmacokinetics2▲ 4.8×4 topics
  30. Chronic Pain2▲ 5.4×2 topics
  31. Central Sensitization2▲ 18×1 topic
  32. Nociception2▲ 24×1 topic
  33. TGF-ß2▲ 6.9×3 topics
  34. Glycosylation1▲ 9.3×3 topics
  35. Monoclonal Antibodies1▲ 11×3 topics
  36. Click Chemistry1▲ 18×1 topic
  37. Copper-Catalyzed Cycloaddition1▲ 35×1 topic
  38. Emotions1▲ 19×2 topics
  39. Interstitial Lung Disease1▲ 15×2 topics
  40. Molecular Docking1▲ 8.0×3 topics

Which research topics does Bridge Pharma (United States) publish most on?

By volume in 2022-now: Amyloidosis: Diagnosis, Treatment, Outcomes, Structural Engineering and Vibration Analysis, Myeloproliferative Neoplasms: Diagnosis and Treatment and Parathyroid Disorders and Treatments.

Amyloidosis: Diagnosis, Treatment, Outcomes: 3 fractional worksStructural Engineering and Vibration Analysis: 3 fractional worksMyeloproliferative Neopl…2Myeloproliferative Neoplasms: Diagnosis and Treatment: 2 fractional worksParathyroid Disorders an…2Parathyroid Disorders and Treatments: 2 fractional worksCoagulation, Bradykinin, Polyphosphates, and Angioedema: 2 fractional worksPain Mechanisms and Treatments: 2 fractional worksClick Chemistry and Appl…1Click Chemistry and Applications: 1 fractional worksTryptophan and brain disorders: 1 fractional worksPharmaceutical studies and practices: 1 fractional worksPharmacological Receptor Mechanisms and Effects: 1 fractional works
Molecular BiologyCivil and Structural EngineeringGeneticsNephrology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 3 works
  2. 2 Structural Engineering and Vibration Analysis Civil and Structural Engineering 3 works
  3. 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
  4. 4 Parathyroid Disorders and Treatments Nephrology 2 works
  5. 5 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 2 works
  6. 6 Pain Mechanisms and Treatments Physiology 2 works
  7. 7 Click Chemistry and Applications Organic Chemistry 1 works
  8. 8 Tryptophan and brain disorders Biological Psychiatry 1 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
  10. 10 Pharmacological Receptor Mechanisms and Effects Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.4%not open62.6%

World: 40% of research is openly available.

with international co-authors29.8%domestic only70.2%

World: 18% is written across borders.

How has Bridge Pharma (United States)'s research output changed?

Output in 2022-2025 was 60% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Bridge Pharma (United States) as a percentage of every work published that year, 0.00033% in 2024.

still counting0.00050%0.0010%0.0015%Bridge Pharma (United States)0.00098% in 202519801990200020102020

Fractional works of Bridge Pharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Sarasota

All research institutions in Sarasota

Share Bridge Pharma (United States)'s ranking

Bridge Pharma (United States) on Science Explorer

A card with Bridge Pharma (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Bridge Pharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.